Prof Gantier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cancer drug could play a role in limiting the damaging effects of lung disease in COVID-19 patients

A cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients, thanks to new research at Hudson Institute of Medical Research.

Danielle ellisMichael gantierTomalika ullahVincent institute of medical researchHealth gabrielle williamsNature communicationsHudson institute of medical researchFrancis crick instituteMonash universityTreatments medical research fundUniversity of adelaideHudson instituteAssociate professor michael gantierAssociate professorProf gantierVictorian government

Cancer drug limits COVID inflammation

Cancer drug limits COVID inflammation
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Tomalika ullahMichael gantierNature communicationsTreatments medical research fundFrancis crick instituteVincent institute of medical researchHudson instituteMonash universityHealth gabrielle williamsHudson institute associate professor michael gantierUniversity of adelaideProf gantierAssociate professor michaelAssociate professor michael gantierProf michaelVictorian government

RNA - changing face of modern medicine

RNA - changing face of modern medicine
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Michael gantierRna victoria activation program grantPharmorage pty ltdHudson instituteAssociate professor michael gantierAssociate professor michaelProfessor michaelActivation program grantProf gantierVictorian government

Noxopharm Ltd has Sofra™ inflammation research presented at European Molecular Biology Organisation event; commercial opportunities await

The research underpinning Noxopharm Ltd (ASX:NOX, OTC:NOXOF)’s Sofra™ technology platform has been showcased by the Hudson Institute of Medical Research’s.

Gisela mautnerNoxopharm ltdHudson instituteEuropean molecular biology organisationHudson institutea prof michael gantierMedical researchAssociate professor michael gantierProf gantierProfessor gantierProf michael gantier

Victorian government funding boost for new anti-inflammatory treatments

Victorian government funding boost for new anti-inflammatory treatments
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Elizabeth hartlandMichael gantierHudson institute is australiaHudson instituteHudson institute of medical researchPharmorage pty ltdProfessor michael gantierVictorian governmentMedical researchAssociate professor michael gantierProfessor elizabeth hartlandProf gantier